Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Although there are molecularly distinct subtypes of prostate cancer, no molecular classification system is used clinically. The ribonucleotide reductase small subunit M2 (RRM2) gene plays an oncogenic role in many cancers. Our previous study elucidated comprehensive molecular mechanisms of RRM2 in p...

Full description

Bibliographic Details
Main Authors: Ying Z. Mazzu, Joshua Armenia, Subhiksha Nandakumar, Goutam Chakraborty, Yuki Yoshikawa, Lina E. Jehane, Gwo‐Shu Mary Lee, Mohammad Atiq, Nabeela Khan, Nikolaus Schultz, Philip W. Kantoff
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Molecular Oncology
Subjects:
molecular subtyping
PAM50
PCS subtyping
prostate cancer
RRM2
Online Access:https://doi.org/10.1002/1878-0261.12706

Internet

https://doi.org/10.1002/1878-0261.12706

Similar Items